Compare HVT & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HVT | LENZ |
|---|---|---|
| Founded | 1885 | 2019 |
| Country | United States | United States |
| Employees | 2334 | 152 |
| Industry | Other Specialty Stores | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 379.2M | 286.9M |
| IPO Year | N/A | 2021 |
| Metric | HVT | LENZ |
|---|---|---|
| Price | $22.70 | $9.37 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $44.00 |
| AVG Volume (30 Days) | 98.6K | ★ 879.3K |
| Earning Date | 05-01-2026 | 05-06-2026 |
| Dividend Yield | ★ 5.79% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $19,088,000.00 |
| Revenue This Year | $8.83 | $50.42 |
| Revenue Next Year | $8.70 | $197.16 |
| P/E Ratio | $22.08 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.76 | $8.25 |
| 52 Week High | $27.67 | $50.19 |
| Indicator | HVT | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 55.27 | 42.31 |
| Support Level | $21.97 | $8.99 |
| Resistance Level | $23.45 | $10.29 |
| Average True Range (ATR) | 0.67 | 0.62 |
| MACD | 0.16 | 0.13 |
| Stochastic Oscillator | 74.53 | 29.51 |
Haverty Furniture Companies Inc is a specialty retailer of residential furniture and accessories. It provides various products such as Sofa Tables, Sleepers, End Tables, Cocktail Tables, Accent Pieces, Display Cabinets, Wall Decor, floral and Tress, and other related products. The company operates in the Southern and Midwestern U.S. All its activities are encompassed in its Merchandise division. The company derives the majority of its revenue from its upholstery products and, secondarily, from bedroom furniture.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.